Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Warmerdam, L.J.C. van
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(3)
+
-
Availability
Metadata Only
(3)
+
-
Faculty
Leiden University Medical Center (LUMC)
(3)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(3)
+
-
Author
Warmerdam, L.J.C. van
(3)
+
-
Charehbili, A.
(2)
+
-
Heijns, J.B.
(2)
+
-
Kroep, J.R.
(2)
+
-
Laarhoven, H.W.M. van
(2)
+
-
Liefers, G.J.
(2)
+
-
Nortier, J.W.R.
(2)
+
-
Putter, H.
(2)
+
-
Smit, V.T.H.B.M.
(2)
+
-
Ven, S. van de
(2)
+
-
Show more
Language
en
(3)
+
-
Search results
(1 - 3 of 3)
show grid
show list
save search
Groot, S. de; Pijl, H.; Charehbili, A.; Ven, S. van de; Smit, V.T.H.B.M.; Meershoek-Klein Kranenbarg, E.; ... ; Dutch Breast Canc Res Grp
2019
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)
Article / Letter to editor
metadata only
Charehbili, A.; Ven, S. van de; Smit, V.T.H.B.M.; Kranenbarg, E.K.; Hamdy, N.A.T.; Putter, H.; ... ; Dutch Breast Canc Res Grp BOOG
2014
Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)
Article / Letter to editor
metadata only
Slingerland, M.; Guchelaar, H.J.; Rosing, H.; Scheulen, M.E.; Warmerdam, L.J.C. van; Beijnen, J.H.; Gelderblom, H.
2013
Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) Formulation and Paclitaxel in Polyethoxylated Castor Oil: A Randomized, Two-Period Crossover Study in Patients With Advanced Cancer
Article / Letter to editor
metadata only